| Pharmaceutical applications of hot-melt extrusion: part I MM Crowley, F Zhang, MA Repka, S Thumma, SB Upadhye, ... Drug development and industrial pharmacy 33 (9), 909-926, 2007 | 1107 | 2007 |
| Pharmaceutical applications of hot-melt extrusion: Part II MA Repka, SK Battu, SB Upadhye, S Thumma, MM Crowley, F Zhang, ... Drug development and industrial pharmacy 33 (10), 1043-1057, 2007 | 599 | 2007 |
| Applications of hot-melt extrusion for drug delivery MA Repka, S Majumdar, S Kumar Battu, R Srirangam, SB Upadhye Expert opinion on drug delivery 5 (12), 1357-1376, 2008 | 327 | 2008 |
| Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants SK Battu, MA Repka, S Majumdar, M Rao Y Drug development and industrial pharmacy 33 (11), 1225-1232, 2007 | 252 | 2007 |
| Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery SK Battu, MA Repka, S Maddineni, AG Chittiboyina, MA Avery, ... Aaps Pharmscitech 11, 1466-1475, 2010 | 232 | 2010 |
| Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea BJ Gurley, A Swain, MA Hubbard, DK Williams, G Barone, F Hartsfield, ... Molecular nutrition & food research 52 (7), 755-763, 2008 | 226 | 2008 |
| Gauging the clinical significance of P‐glycoprotein‐mediated herb‐drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin … BJ Gurley, A Swain, DK Williams, G Barone, SK Battu Molecular nutrition & food research 52 (7), 772-779, 2008 | 197 | 2008 |
| Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology CR Palem, S Kumar Battu, S Maddineni, R Gannu, MA Repka, ... Pharmaceutical development and technology 18 (1), 186-195, 2013 | 75 | 2013 |
| Development, optimization and in vivo characterization of domperidone-controlled release hot-melt-extruded films for buccal delivery CR Palem, NR Dudhipala, SK Battu, MA Repka, M Rao Yamsani Drug development and industrial pharmacy 42 (3), 473-484, 2016 | 70 | 2016 |
| Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates S Maddineni, SK Battu, J Morott, S Majumdar, SN Murthy, MA Repka AAPS PharmSciTech 16, 444-454, 2015 | 41 | 2015 |
| Immediate release, abuse deterrent pharmaceutical compositions SN Raman, JH Park, TA Diezi, CJ Herman, SK Battu, EA Burge US Patent 9,993,422, 2018 | 36 | 2018 |
| Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments S Maddineni, SK Battu, J Morott, M Soumyajit, MA Repka Journal of Pharmacy and Pharmacology 66 (2), 309-322, 2014 | 31 | 2014 |
| Combined dosage form of pioglitazone and felodipine as mucoadhesive pellets via hot melt extrusion for improved buccal delivery with application of quality by design approach CR Palem, N Dudhipala, SK Battu, S Goda, MA Repka, MR Yamsani Journal of Drug Delivery Science and Technology 30, 209-219, 2015 | 29 | 2015 |
| Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: In vitro and ex vivo characterization CR Palem, S Kumar Battu, R Gannu, VV Yamsani, MA Repka, ... Pharmaceutical Development and Technology 17 (3), 321-332, 2012 | 25 | 2012 |
| Abuse deterrent solid dosage form for immediate release with functional score SN Raman, JH Park, SK Battu, EA Burge, DW Bogan US Patent 9,301,918, 2016 | 18 | 2016 |
| Hydrophobic Peptide Salts for Extended Release Compositions J Ang, SK Battu, J Laber, K Estrada, J LeBowitz, J Chou US Patent App. 17/634,034, 2022 | | 2022 |
| Pre-formulation and formulation Considerations for Transmucosal and Oral Delivery of Compounds of Natural Origin Produced Utilizing Hot-Melt Extrusion Technology SK Battu THE UNIVERSITY OF MISSISSIPPI, 2011 | | 2011 |
| Preformulation Characterization of a Novel Delta-9-Tetrahydrocannabinol Amino Acid Prodrug S Battu, Z Rahman, S Majumdar, W Gul, MA ElSohly, MA Repka Planta Medica 75 (04), P-90, 2009 | | 2009 |